Loading…
Underlying
Underlying Price
$39.57
Type
Call
Strike
40
Expiration
May 21, 2027
DTE
226d
Moneyness
OTM
Intrinsic
$0.00
EWTX 40 Call Across Expirations
| Expiration | DTE | Last | Change | Vol | Open Int |
|---|---|---|---|---|---|
| Oct 16, 2026 | 9d | $2.10 | -19.54% | 5 | 150 |
| Nov 20, 2026 | 44d | $3.50 | -18.79% | 8 | 27 |
| Dec 18, 2026 | 72d | $11.25 | +80.00% | 1 | 0 |
| Jan 15, 2027 | 100d | $8.21 | -18.71% | 100 | 39 |
| Feb 19, 2027 | 135d | $7.66 | -21.84% | 1 | 1 |
| Mar 19, 2027 | 163d | $9.35 | -16.89% | 52 | 17 |
| May 21, 2027 | 226d | — | — | 0 | 0 |
EWTX Profile
edgewise therapeutics is a biotechnology company focused on developing novel therapies for diseases involving skeletal muscle. the company is headquartered in boulder, co and received its series a financing from orbimed.